Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation

BACKGROUND: The standard treatment of stage III N2 small cell lung cancer (SCLC) is concurrent chemoradiation, and surgery is not recommended. This study was aimed to evaluate whether surgery has survival benefits in patients with stage III N2 SCLC and investigate the factors influencing survival of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Yanfei, Ma, Yuchao, Feng, Wei, Lu, Hongwei, Jin, Longyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404296/
https://www.ncbi.nlm.nih.gov/pubmed/34461929
http://dx.doi.org/10.1186/s12957-021-02364-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404296/
https://www.ncbi.nlm.nih.gov/pubmed/34461929
http://dx.doi.org/10.1186/s12957-021-02364-6

Ejemplares similares